153 related articles for article (PubMed ID: 38524629)
1. Prediction of immunotherapy response in idiopathic membranous nephropathy using deep learning-pathological and clinical factors.
Wei X; Long M; Fan Z; Hou Y; Zhu X; Qu Z; Du Y
Front Endocrinol (Lausanne); 2024; 15():1328579. PubMed ID: 38524629
[TBL] [Abstract][Full Text] [Related]
2. Machine learning model to estimate probability of remission in patients with idiopathic membranous nephropathy.
Duo L; Chen L; Zuo Y; Guo J; He M; Zhao H; Kang Y; Tang W
Int Immunopharmacol; 2023 Dec; 125(Pt A):111126. PubMed ID: 37913570
[TBL] [Abstract][Full Text] [Related]
3. Using Machine Learning to Identify Risk Factors and Establishing a Clinical Prediction Model to Predict Atherosclerosis Complications in Idiopathic Membranous Nephropathy.
Chen Y; He Y; Xing G
Discov Med; 2023 Aug; 35(177):517-524. PubMed ID: 37553305
[TBL] [Abstract][Full Text] [Related]
4. Prognostic prediction of idiopathic membranous nephropathy using interpretable machine learning.
Liu Y; Lu Y; Li W; Wang Y; Zhang Z; Yang X; Yang Y; Li R; Zhou X
Ren Fail; 2023; 45(2):2251597. PubMed ID: 37724550
[TBL] [Abstract][Full Text] [Related]
5. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.
Bazzi C; Usui T; Rizza V; Casellato D; Gallieni M; Nangaku M
Nephrology (Carlton); 2018 Feb; 23(2):175-182. PubMed ID: 27764902
[TBL] [Abstract][Full Text] [Related]
6. Application of miR-193a/WT1/PODXL axis to estimate risk and prognosis of idiopathic membranous nephropathy.
Zhang W; Ren Y; Li J
Ren Fail; 2019 Nov; 41(1):704-717. PubMed ID: 31352863
[No Abstract] [Full Text] [Related]
7. Detection and clinical significance of glomerular M-type phospholipase A
Liu H; Luo W; Gong S; Ding X
Intern Med J; 2016 Nov; 46(11):1318-1322. PubMed ID: 27554390
[TBL] [Abstract][Full Text] [Related]
8. Comparison of prognostic, clinical, and renal histopathological characteristics of overlapping idiopathic membranous nephropathy and IgA nephropathy versus idiopathic membranous nephropathy.
Chen X; Chen Y; Shi K; Lv Y; Tong H; Zhao G; Chen C; Chen B; Li D; Lu Z
Sci Rep; 2017 Sep; 7(1):11468. PubMed ID: 28904360
[TBL] [Abstract][Full Text] [Related]
9. Renal Phospholipase A2 Receptor and the Clinical Features of Idiopathic Membranous Nephropathy.
Xu NX; Xie QH; Sun ZX; Wang J; Li Y; Wang L; Liu SJ; Xue J; Hao CM
Chin Med J (Engl); 2017 Apr; 130(8):892-898. PubMed ID: 28397717
[TBL] [Abstract][Full Text] [Related]
10. Renal outcomes of idiopathic and atypical membranous nephropathy in adult Chinese patients: a single center retrospective cohort study.
Jiang Z; Cai M; Dong B; Yan Y; Wang Y; Li X; Shao C; Zuo L
BMC Nephrol; 2021 Apr; 22(1):148. PubMed ID: 33888083
[TBL] [Abstract][Full Text] [Related]
11. The impact of coexisting diabetes mellitus on clinical outcomes in patients with idiopathic membranous nephropathy: a retrospective observational study.
Xie Z; Li Z; Dong W; Chen Y; Li R; Wu Y; Liang H; Ye Z; Liu S; Shi W; Liang X
BMC Nephrol; 2020 Jun; 21(1):224. PubMed ID: 32532223
[TBL] [Abstract][Full Text] [Related]
12. Clinical and pathological analysis of hepatitis B virus-related membranous nephropathy and idiopathic membranous nephropathy.
Li P; Wei RB; Tang L; Wu J; Zhang XG; Chen XM
Clin Nephrol; 2012 Dec; 78(6):456-64. PubMed ID: 23164414
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological features and outcome in elderly patients with idiopathic membranous nephropathy.
Liang J; Hao W; Xia F; Zhao Z; Wu Y; Yu F; Hu W; Fang X; Liu W
Ren Fail; 2023 Dec; 45(1):2212081. PubMed ID: 37194712
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study.
Xie Z; Dong W; Li Z; Chen Y; Song L; Li R; Wu Y; Fu L; Liang H; Tao Y; Xie J; Wang W; Liu S; Ye Z; Shi W; Liang X
Nephrology (Carlton); 2020 Mar; 25(3):219-229. PubMed ID: 31900967
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic efficacy of serum anti-phospholipase A2 receptor antibodies for idiopathic membranous nephropathy in patients with diabetic kidney disease.
Wang Q; Dong ZY; Zhang WG; Liu XM; Qu YL; Duan SW; Huang MJ; Zhou JH; Chen P; Zhu HY; Zhang L; Sun XF; Cai GY; Chen XM
Clin Chim Acta; 2020 Mar; 502():222-226. PubMed ID: 31730818
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and prognosis of patients with idiopathic membranous nephropathy with kidney tubulointerstitial damage.
Sun M; Li P; Dong J; Li Z; Li C; Zhang S; Chen B
Ren Fail; 2023 Dec; 45(1):2205951. PubMed ID: 37125531
[TBL] [Abstract][Full Text] [Related]
17. Response to immunosuppressive therapy in PLA
Wang J; Xie Q; Sun Z; Xu N; Li Y; Wang L; Liu S; Xue J; Hao CM
BMC Nephrol; 2017 Jul; 18(1):227. PubMed ID: 28693446
[TBL] [Abstract][Full Text] [Related]
18. Deep learning-based framework for the distinction of membranous nephropathy: a new approach through hyperspectral imagery.
Tu T; Wei X; Yang Y; Zhang N; Li W; Tu X; Li W
BMC Nephrol; 2021 Jun; 22(1):231. PubMed ID: 34147076
[TBL] [Abstract][Full Text] [Related]
19. [Expression of renal PLA2R in patients with idiopathic membranous nephropathy and its relationship with the curative effect of immunotherapy].
Wang LJ; Shang MH; Zhuge YF; Huang YX; Rong S; Tang ZH; Bao JF; Yu Q; Yuan WJ
Zhonghua Yi Xue Za Zhi; 2016 Jan; 96(1):4-8. PubMed ID: 26792599
[TBL] [Abstract][Full Text] [Related]
20. GDF-15 and sST-2 act as biomarkers of disease severity but not independent predictors in idiopathic membranous nephropathy.
Wu L; Luo L; Zhou L; Li N; Qin X
Int Immunopharmacol; 2022 Oct; 111():109150. PubMed ID: 36027852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
